1. Home
  2. MEDP vs COHR Comparison

MEDP vs COHR Comparison

Compare MEDP & COHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MEDP
  • COHR
  • Stock Information
  • Founded
  • MEDP 1992
  • COHR 1971
  • Country
  • MEDP United States
  • COHR United States
  • Employees
  • MEDP N/A
  • COHR N/A
  • Industry
  • MEDP Biotechnology: Commercial Physical & Biological Resarch
  • COHR Electronic Components
  • Sector
  • MEDP Health Care
  • COHR Technology
  • Exchange
  • MEDP Nasdaq
  • COHR Nasdaq
  • Market Cap
  • MEDP 13.4B
  • COHR 20.2B
  • IPO Year
  • MEDP 2016
  • COHR 1987
  • Fundamental
  • Price
  • MEDP $607.00
  • COHR $157.95
  • Analyst Decision
  • MEDP Hold
  • COHR Strong Buy
  • Analyst Count
  • MEDP 11
  • COHR 14
  • Target Price
  • MEDP $451.70
  • COHR $137.77
  • AVG Volume (30 Days)
  • MEDP 337.9K
  • COHR 4.6M
  • Earning Date
  • MEDP 10-22-2025
  • COHR 11-05-2025
  • Dividend Yield
  • MEDP N/A
  • COHR N/A
  • EPS Growth
  • MEDP 25.36
  • COHR N/A
  • EPS
  • MEDP 14.32
  • COHR 0.76
  • Revenue
  • MEDP $2,358,373,000.00
  • COHR $6,043,358,000.00
  • Revenue This Year
  • MEDP $21.48
  • COHR $10.48
  • Revenue Next Year
  • MEDP $11.90
  • COHR $11.20
  • P/E Ratio
  • MEDP $42.51
  • COHR $207.63
  • Revenue Growth
  • MEDP 13.88
  • COHR 20.80
  • 52 Week Low
  • MEDP $250.05
  • COHR $45.58
  • 52 Week High
  • MEDP $625.00
  • COHR $168.57
  • Technical
  • Relative Strength Index (RSI)
  • MEDP 68.95
  • COHR 67.30
  • Support Level
  • MEDP $573.07
  • COHR $145.41
  • Resistance Level
  • MEDP $602.54
  • COHR $168.57
  • Average True Range (ATR)
  • MEDP 20.39
  • COHR 7.73
  • MACD
  • MEDP -0.47
  • COHR 2.99
  • Stochastic Oscillator
  • MEDP 65.24
  • COHR 80.61

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

About COHR Coherent Corp.

Coherent Corp engaged in materials, networking, and lasers, is a vertically integrated manufacturing company that develops, manufactures, and markets engineered materials, optoelectronic components and devices, and lasers for use in the industrial, communications, electronics and instrumentation markets. The firm operates in three segments Networking, Materials, and Lasers Segment. It generates maximum revenue from Networking segment. The company geographically operates in North America. Europe, China, Japan and Rest of the world.

Share on Social Networks: